Actively Recruiting
Pilot Study of Metformin for Safety and Feasibility in Patients with Clonal Cytopenia of Undetermined Significance and Lower-Risk Myelodysplastic Neoplasms
Led by Kirsten Grønbæk · Updated on 2024-11-22
40
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and feasibility of using metformin in patients with clonal cytopenia of undetermined significance CCUS or lower-risk myelodysplastic neoplasms LR-MDS, conditions that may progress to leukemia. This phase 2 pilot study explores biological features such as bone marrow fat tissue, gut microbiota, and intestinal permeability that may play a role in disease progression and could be targets for metformin treatment. The study also compares findings to healthy elderly controls for better understanding. Participants in the main treatment group will receive up to 2000 mg of metformin daily for 12 months, with a slow increase to the full dose over six weeks. The study is divided into three parts the first investigates biological markers in both patients and healthy volunteers the second assesses metformin safety, adherence, and possible anti-leukemic mechanisms in patients and the third compares safety and early efficacy of metformin to historical placebo controls from a previous randomized study. During the 12 months of treatment, participants will be monitored for safety by tracking serious side effects and the highest tolerated dose. Feasibility will be assessed through recruitment, completion, and compliance rates. Researchers will also measure changes in genetic mutations, patient-reported health outcomes, bone marrow fat, bone density, gut bacteria, intestinal permeability, gene expression, protein profiles, and immune markers. The involvement includes various scans, blood and bone marrow tests, and questionnaires, with the total participation lasting approximately one year.
CONDITIONS
Brief Title
Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS
Research Team
K
Kirsten Grønbæk, Professor, MD
S
Stine Ulrik Mikkelsen, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here